Main menu

Pages

The Mesothelioma drug Cisplatin was injected through



chemotherapy drugs, asbestos advocates, and lawsuits. Recently, Scottish researchers from Strathclyde University in Glasgow discovered a new chemotherapy delivery system for patients suffering from malignant pleural mesothelioma and lung cancer. 


Mesothelioma is a cancer that can develop in the cavities of the lungs, heart, or abdomen. Precisely because of the proximity of the pleura to the lung, many people mistakenly think of the pleural mesothelioma as a form of lung cancer. It is rare cancer that occurs in the thin tissue that covers most of your internal organs (mesothelium). Mesothelioma is a rare cancer of the lining of the lungs and abdominal area caused by exposure to asbestos fibers. Mesothelioma, a rare tumor, usually occurs in the pleura, peritoneum and cardiac pericardium, and so on. The majority are malignant, with a short survival period and a high mortality rate. 


Dr. Chris Carter, project manager and university lecturer at the Strathclyde Institute of Pharmacy and Biosciences, with Professor Alex Mullen and dr. Valeria Ferro discovered that a common chemotherapy drug is used to treat malignant pleural mesothelioma and lung cancer more effectively when administered. evaporated state. The chemotherapy drug cisplatin is an important drug for the treatment of mesothelioma, the chemotherapy drugs used to treat mesothelioma by intravenous drip. This remedy becomes effective after a few hours. the effect will be reduced. However, the Scottish research team has discovered that if Cisplatin is administered by inhalation instead of intravenous drip, the drug begins to work faster and more effectively on the cancerous tissue. 


The treatment of malignant pleural mesothelioma is not yet effective treatment methods. When most people talk about "mesothelioma", they usually talk about malignant pleural mesothelioma. the inhalation of the chemotherapy directly into the lungs is directed only at the cancer cells instead of the healthy cells, which are often in direct contact with an intravenous drip. The powerful chemotherapeutic agent cisplatin damages healthy cells by killing cancer cells and delays the overall treatment of mesothelioma, which further puts the patient at risk. With this new mesothelioma medication system, the course of treatment will be reduced, it will reduce the side effects of Cisplatin: including vomiting, milking, hair loss, and dehydration. 

reaction:

Comments